Compare LARK & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LARK | LNSR |
|---|---|---|
| Founded | 1885 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Electronics |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 147.7M | 146.7M |
| IPO Year | 2001 | 2005 |
| Metric | LARK | LNSR |
|---|---|---|
| Price | $24.74 | $5.87 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $12.50 |
| AVG Volume (30 Days) | 5.3K | ★ 186.4K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.52% | N/A |
| EPS Growth | ★ 1.35 | N/A |
| EPS | ★ 2.41 | N/A |
| Revenue | N/A | ★ $53,494,000.00 |
| Revenue This Year | N/A | $19.55 |
| Revenue Next Year | N/A | $35.89 |
| P/E Ratio | $9.91 | ★ N/A |
| Revenue Growth | N/A | ★ 26.87 |
| 52 Week Low | $23.43 | $5.35 |
| 52 Week High | $31.04 | $14.26 |
| Indicator | LARK | LNSR |
|---|---|---|
| Relative Strength Index (RSI) | 41.35 | 22.39 |
| Support Level | $23.57 | N/A |
| Resistance Level | $27.06 | $12.85 |
| Average True Range (ATR) | 0.66 | 0.66 |
| MACD | -0.05 | -0.26 |
| Stochastic Oscillator | 36.44 | 7.90 |
Landmark Bancorp Inc is the bank holding company for Landmark National Bank, which is dedicated to providing quality financial and banking services. The Bank has continued to focus on increasing its originations of commercial, commercial real estate (CRE), and agricultural loans, which management believes will be more profitable and provide more growth for the Bank than traditional one-to-four-family residential real estate lending. In addition, it also invests in certain investment and mortgage-related securities using deposits and other borrowings as funding sources. Its primary deposit gathering and lending markets are geographically diversified with locations in central, eastern, southeast, and southwest Kansas.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe and Asia.